The clip-segment of the von Willebrand domain 1 of the BMP modulator protein crossveinless 2 is preformed

Molecules

Volumn 18, Issue 10, 2013, Pages 11658-11682

  Fiebig, Juliane E ^a   Weidauer, Stella E ^a   Qiu, Li Yan ^b   Bauer, Markus ^a   Schmieder, Peter ^c   Beerbaum, Monika ^c   Zhang, Jin Li ^b   Oschkinat, Hartmut ^c   Sebald, Walter ^b   Mueller, Thomas D ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

BMP antagonist; Bone morphogenetic proteins; NMR spectroscopy; Protein protein recognition; Superfamily; TGF ; Von Willebrand type C domain

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CROSSVEINLESS 2 PROTEIN , ZEBRAFISH; CYSTINE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PROTEIN BINDING; ZEBRAFISH PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HYDROGEN BOND; METABOLISM; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; ZEBRA FISH; ARTICLE; PROTEIN BINDING;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CONSERVED SEQUENCE; CYSTINE; GTPASE-ACTIVATING PROTEINS; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, SECONDARY; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84886620093     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules181011658     Document Type: Article

References (55)

1. Nickel, J.; Sebald, W.; Groppe, J.C.; Mueller, T.D. Intricacies of BMP receptor assembly. Cytokine Growth Factor Rev. 2009, 20, 367-377.
2. Mueller, T.D.; Nickel, J. Promiscuity and specificity in BMP receptor activation. FEBS Lett. 2012, 586, 1846-1859.
3. Graff, J.M. Embryonic patterning: To BMP or not to BMP, that is the question. Cell 1997, 89, 171-174.
4. Kishigami, S.; Mishina, Y. BMP signaling and early embryonic patterning. Cytokine Growth Factor Rev. 2005, 16, 265-278.
5. Bond, A.M.; Bhalala, O.G.; Kessler, J.A. The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturation. Dev. Neurobiol. 2012, 72, 1068-1084.
6. Botchkarev, V.A.; Sharov, A.A. BMP signaling in the control of skin development and hair follicle growth. Differentiation 2004, 72, 512-526.
7. Schneider, M.D.; Gaussin, V.; Lyons, K.M. Tempting fate: BMP signals for cardiac morphogenesis. Cytokine Growth Factor Rev. 2003, 14, 1-4.
8. Simic, P.; Vukicevic, S. Bone morphogenetic proteins in development and homeostasis of kidney. Cytokine Growth Factor Rev. 2005, 16, 299-308.
9. Zaret, K.S.; Watts, J.; Xu, J.; Wandzioch, E.; Smale, S.T.; Sekiya, T. Pioneer factors, genetic competence, and inductive signaling: Programming liver and pancreas progenitors from the endoderm. Cold Spring Harb. Symp. Quant. Biol. 2008, 73, 119-126.
10. Mundlos, S. The brachydactylies: a molecular disease family. Clin. Genet. 2009, 76, 123-136.
11. Reddi, A.H. Cartilage morphogenetic proteins: Role in joint development, homoeostasis, and regeneration. Ann. Rheum Dis. 2003, 62 (Suppl 2), ii73-ii78.
12. Zhao, G.Q. Consequences of knocking out BMP signaling in the mouse. Genesis 2003, 35, 43-56.
13. Kaplan, F.S.; Chakkalakal, S.A.; Shore, E.M. Fibrodysplasia ossificans progressiva: Mechanisms and models of skeletal metamorphosis. Dis. Model. Mech. 2012, 5, 756-762.
14. Bandyopadhyay, A.; Yadav, P.S.; Prashar, P. BMP signaling in development and diseases: A pharmacological perspective. Biochem. Pharmacol. 2013, 85, 857-864.
15. Massague, J. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 2000, 1, 169-178.
16. Miyazono, K.; Maeda, S.; Imamura, T. BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 2005, 16, 251-263.
17. Hellmann, T.V.; Nickel, J.; Mueller, T.D. Missense Mutations in GDF5 Signaling: Molecular Mechanisms behind Skeletal Malformation. In Gene Mutation; Cooper, D., Chen, J.-M., Eds.; In Tech: Rijeka, Croatia, 2012.
18. Gazzerro, E.; Canalis, E. Bone morphogenetic proteins and their antagonists. Rev. Endocr. Metab. Disord. 2006, 7, 51-65.
19. Cash, J.N.; Rejon, C.A.; McPherron, A.C.; Bernard, D.J.; Thompson, T.B. The structure of myostatin:follistatin 288: Insights into receptor utilization and heparin binding. EMBO J. 2009, 28, 2662-2676.
20. Groppe, J.; Greenwald, J.; Wiater, E.; Rodriguez-Leon, J.; Economides, A.N.; Kwiatkowski, W.; Affolter, M.; Vale, W.W.; Izpisua Belmonte, J.C.; Choe, S. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 2002, 420, 636-642.
21. Harrington, A.E.; Morris-Triggs, S.A.; Ruotolo, B.T.; Robinson, C.V.; Ohnuma, S.; Hyvonen, M. Structural basis for the inhibition of activin signalling by follistatin. EMBO J. 2006, 25, 1035-1045.
22. Thompson, T.B.; Lerch, T.F.; Cook, R.W.; Woodruff, T.K.; Jardetzky, T.S. The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. Dev. Cell 2005, 9, 535-543.
23. Zhang, J.L.; Qiu, L.Y.; Kotzsch, A.; Weidauer, S.; Patterson, L.; Hammerschmidt, M.; Sebald, W.; Mueller, T.D. Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding. Dev. Cell 2008, 14, 739-750.
24. Zhang, J.L.; Huang, Y.; Qiu, L.Y.; Nickel, J.; Sebald, W. Von Willebrand factor type C domain-containing proteins regulate bone morphogenetic protein signaling through different recognition mechanisms. J. Biol. Chem. 2007, 282, 20002-20014.
25. Mancuso, D.J.; Tuley, E.A.; Westfield, L.A.; Worrall, N.K.; Shelton-Inloes, B.B.; Sorace, J.M.; Alevy, Y.G.; Sadler, J.E. Structure of the gene for human von Willebrand factor. J. Biol. Chem. 1989, 264, 19514-19527.
26. Bork, P. Shuffled domains in extracellular proteins. FEBS Lett. 1991, 286, 47-54.
27. Patthy, L. Detecting homology of distantly related proteins with consensus sequences. J. Mol. Biol. 1987, 198, 567-577.
28. Hunt, L.T.; Barker, W.C. Von Willebrand factor shares a distinctive cysteine-rich domain with thrombospondin and procollagen. Biochem. Biophys. Res. Commun. 1987, 144, 876-882.
29. Schultz, J.; Milpetz, F.; Bork, P.; Ponting, C.P. SMART, a simple modular architecture research tool: Identification of signaling domains. Proc. Natl. Acad. Sci. USA 1998, 95, 5857-5864.
30. Punta, M.; Coggill, P.C.; Eberhardt, R.Y.; Mistry, J.; Tate, J.; Boursnell, C.; Pang, N.; Forslund, K.; Ceric, G.; Clements, J.; et al. The Pfam protein families database. Nucleic Acids Res. 2012, 40, D290-D301.
31. Garcia Abreu, J.; Coffinier, C.; Larrain, J.; Oelgeschlager, M.; de Robertis, E.M. Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems. Gene 2002, 287, 39-47.
32. Gong, Y.; Krakow, D.; Marcelino, J.; Wilkin, D.; Chitayat, D.; Babul-Hirji, R.; Hudgins, L.; Cremers, C.W.; Cremers, F.P.; Brunner, H.G.; et al. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat. Genet. 1999, 21, 302-304.
33. Hirshoren, N.; Gross, M.; Banin, E.; Sosna, J.; Bargal, R.; Raas-Rothschild, A. P35S mutation in the NOG gene associated with Teunissen-Cremers syndrome and features of multiple NOG joint-fusion syndromes. Eur. J. Med. Genet. 2008, 51, 351-357.
34. Mangino, M.; Flex, E.; Digilio, M.C.; Giannotti, A.; Dallapiccola, B. Identification of a novel NOG gene mutation (P35S) in an Italian family with symphalangism. Hum. Mutat. 2002, 19, 308.
35. Zhang, J.L.; Patterson, L.J.; Qiu, L.Y.; Graziussi, D.; Sebald, W.; Hammerschmidt, M. Binding between Crossveinless-2 and Chordin von Willebrand factor type C domains promotes BMP signaling by blocking Chordin activity. PLoS One 2010, 5, e12846.
36. Qiu, L.Y.; Zhang, J.L.; Kotzsch, A.; Sebald, W.; Mueller, T.D. Crystallization and preliminary X-ray analysis of the complex of the first von Willebrand type C domain bound to bone morphogenetic protein 2. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2008, 64 (Pt 4), 307-312.
37. Ortenberg, R.; Gon, S.; Porat, A.; Beckwith, J. Interactions of glutaredoxins, ribonucleotide reductase, and components of the DNA replication system of Escherichia coli. Proc. Natl. Acad. Sci. USA 2004, 101, 7439-7444.
38. Ritz, D.; Lim, J.; Reynolds, C.M.; Poole, L.B.; Beckwith, J. Conversion of a peroxiredoxin into a disulfide reductase by a triplet repeat expansion. Science 2001, 294, 158-160.
39. Klages, J.; Kotzsch, A.; Coles, M.; Sebald, W.; Nickel, J.; Muller, T.; Kessler, H. The solution structure of BMPR-IA reveals a local disorder-to-order transition upon BMP-2 binding. Biochemistry 2008, 47, 11930-11939.
40. Watt, M.A.; Lo, R.Y.; Mellors, A. Refolding of recombinant Pasteurella haemolytica A1 glycoprotease expressed in an Escherichia coli thioredoxin gene fusion system. Cell Stress Chaperones 1997, 2, 180-190.
41. Cavanagh, J. Protein NMR Spectroscopy: Principles and Practice; Academic Press: San Diego, CA, USA, 1996; p. xxiii, 587.
42. Clore, G.M.; Gronenborn, A.M. New methods of structure refinement for macromolecular structure determination by NMR. Proc. Natl. Acad. Sci. USA 1998, 95, 5891-5898.
43. Kuszewski, J.; Gronenborn, A.M.; Clore, G.M. Improving the quality of NMR and crystallographic protein structures by means of a conformational database potential derived from structure databases. Protein Sci. 1996, 5, 1067-1080.
44. O'Leary, J.M.; Hamilton, J.M.; Deane, C.M.; Valeyev, N.V.; Sandell, L.J.; Downing, A.K. Solution structure and dynamics of a prototypical chordin-like cysteine-rich repeat (von Willebrand Factor type C module) from collagen IIA. J. Biol. Chem. 2004, 279, 53857-53866.
45. Ambrosio, A.L.; Taelman, V.F.; Lee, H.X.; Metzinger, C.A.; Coffinier, C.; de Robertis, E.M. Crossveinless-2 Is a BMP feedback inhibitor that binds Chordin/BMP to regulate Xenopus embryonic patterning. Dev. Cell 2008, 15, 248-260.
46. Fujisawa, T.; Huang, Y.; Sebald, W.; Zhang, J.L. The binding of von Willebrand factor type C domains of Chordin family proteins to BMP-2 and Tsg is mediated by their SD1 subdomain. Biochem. Biophys. Res. Commun. 2009, 385, 215-219.
47. Ganderton, T.; Wong, J.W.; Schroeder, C.; Hogg, P.J. Lateral self-association of VWF involves the Cys2431-Cys2453 disulfide/dithiol in the C2 domain. Blood 2011, 118, 5312-5318.
48. Bork, P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 1993, 327, 125-130.
49. Larrain, J.; Bachiller, D.; Lu, B.; Agius, E.; Piccolo, S.; de Robertis, E.M. BMP-binding modules in chordin: A model for signalling regulation in the extracellular space. Development 2000, 127, 821-830.
50. Zhou, Y.F.; Eng, E.T.; Zhu, J.; Lu, C.; Walz, T.; Springer, T.A. Sequence and structure relationships within von Willebrand factor. Blood 2012, 120, 449-458.
51. Marley, J.; Lu, M.; Bracken, C. A method for efficient isotopic labeling of recombinant proteins. J. Biomol. NMR 2001, 20, 71-75.
52. Schwieters, C.D.; Kuszewski, J.J.; Clore, G.M. Using Xplor-NIH for NMR molecular structure determination. Progr. Nucl. Magn. Reson. Spectrosc. 2006, 48, 47-62.
53. Brunger, A.T. XPLOR (Version 3.1) A System for X-ray Crystallography and NMR; Yale University, The Howard Hughes Medical Institute and Department of Molecular Biophysics and Biochemistry: New Haven, CT, USA, 1992.
54. Kuszewski, J.; Qin, J.; Gronenborn, A.M.; Clore, G.M. The impact of direct refinement against 13C alpha and 13C beta chemical shifts on protein structure determination by NMR. J. Magn. Reson. B 1995, 106, 92-96.
55. Ruppert, R.; Hoffmann, E.; Sebald, W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur. J. Biochem. 1996, 237, 295-302.